Cargando…

A longitudinal assessment of retinal function and structure in the APP/PS1 transgenic mouse model of Alzheimer’s disease

BACKGROUND: A great body of evidence suggests that there are retinal functional and structural changes that occur in Alzheimer’s disease (AD). However, whether such changes are primary or secondary remains to be elucidated. We studied a range of retinal functional and structural parameters in associ...

Descripción completa

Detalles Bibliográficos
Autores principales: Georgevsky, Dana, Retsas, Stephanie, Raoufi, Newsha, Shimoni, Olga, Golzan, S. Mojtaba
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6774218/
https://www.ncbi.nlm.nih.gov/pubmed/31592131
http://dx.doi.org/10.1186/s40035-019-0170-z
_version_ 1783456038237765632
author Georgevsky, Dana
Retsas, Stephanie
Raoufi, Newsha
Shimoni, Olga
Golzan, S. Mojtaba
author_facet Georgevsky, Dana
Retsas, Stephanie
Raoufi, Newsha
Shimoni, Olga
Golzan, S. Mojtaba
author_sort Georgevsky, Dana
collection PubMed
description BACKGROUND: A great body of evidence suggests that there are retinal functional and structural changes that occur in Alzheimer’s disease (AD). However, whether such changes are primary or secondary remains to be elucidated. We studied a range of retinal functional and structural parameters in association with AD- specific pathophysiological markers in the double transgenic APP/PS1 and control mice across age. METHODS: Electroretinogram (ERG) and optical coherence tomography (OCT) was performed in APP/PS1 and wild type (WT) control mice every 3 months from 3 to 12 months of age. For functional assessment, the a- and b-wave of the ERG, amplitude of oscillatory potentials (OP) and the positive scotopic threshold response (pSTR) were quantified at each time point. For structural assessment, the inner and outer retinal thickness was segmented and measured from OCT scans. Episodic memory was evaluated at 6, 9 and 12 months of age using the novel object recognition test. Amyloid beta (Aβ) distribution in the hippocampus and the retina were visualised at 3, 6 and 12 months of age. Inter- and intra- group analysis was performed to study rate of change for each parameter between the two groups. RESULTS: Inter-group analysis revealed a significant difference in b-wave and OPs of APP/PS1 compared to WT controls starting from 3 months (p < 0.001). There was also a significant difference in the amplitude of pSTR between the two groups starting from 6 months (p < 0.001). Furthermore, a significant difference in the inner retinal thickness, between the two groups, was observed starting from 9 months (p < 0.001). CONCLUSIONS: We observed an age-related decline in retinal functional and structural parameters in both APP/PS1 and WT controls, however, inter-group analysis revealed that inner retinal functional and structural decline is exacerbated in APP/PS1 mice, and that retinal functional changes precede structural changes in this strain. Further studies are required to confirm whether such phenomenon occurs in humans and if studying retinal functional changes can aid-in early assessment of AD. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s40035-019-0170-z) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6774218
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-67742182019-10-07 A longitudinal assessment of retinal function and structure in the APP/PS1 transgenic mouse model of Alzheimer’s disease Georgevsky, Dana Retsas, Stephanie Raoufi, Newsha Shimoni, Olga Golzan, S. Mojtaba Transl Neurodegener Research BACKGROUND: A great body of evidence suggests that there are retinal functional and structural changes that occur in Alzheimer’s disease (AD). However, whether such changes are primary or secondary remains to be elucidated. We studied a range of retinal functional and structural parameters in association with AD- specific pathophysiological markers in the double transgenic APP/PS1 and control mice across age. METHODS: Electroretinogram (ERG) and optical coherence tomography (OCT) was performed in APP/PS1 and wild type (WT) control mice every 3 months from 3 to 12 months of age. For functional assessment, the a- and b-wave of the ERG, amplitude of oscillatory potentials (OP) and the positive scotopic threshold response (pSTR) were quantified at each time point. For structural assessment, the inner and outer retinal thickness was segmented and measured from OCT scans. Episodic memory was evaluated at 6, 9 and 12 months of age using the novel object recognition test. Amyloid beta (Aβ) distribution in the hippocampus and the retina were visualised at 3, 6 and 12 months of age. Inter- and intra- group analysis was performed to study rate of change for each parameter between the two groups. RESULTS: Inter-group analysis revealed a significant difference in b-wave and OPs of APP/PS1 compared to WT controls starting from 3 months (p < 0.001). There was also a significant difference in the amplitude of pSTR between the two groups starting from 6 months (p < 0.001). Furthermore, a significant difference in the inner retinal thickness, between the two groups, was observed starting from 9 months (p < 0.001). CONCLUSIONS: We observed an age-related decline in retinal functional and structural parameters in both APP/PS1 and WT controls, however, inter-group analysis revealed that inner retinal functional and structural decline is exacerbated in APP/PS1 mice, and that retinal functional changes precede structural changes in this strain. Further studies are required to confirm whether such phenomenon occurs in humans and if studying retinal functional changes can aid-in early assessment of AD. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s40035-019-0170-z) contains supplementary material, which is available to authorized users. BioMed Central 2019-10-01 /pmc/articles/PMC6774218/ /pubmed/31592131 http://dx.doi.org/10.1186/s40035-019-0170-z Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Georgevsky, Dana
Retsas, Stephanie
Raoufi, Newsha
Shimoni, Olga
Golzan, S. Mojtaba
A longitudinal assessment of retinal function and structure in the APP/PS1 transgenic mouse model of Alzheimer’s disease
title A longitudinal assessment of retinal function and structure in the APP/PS1 transgenic mouse model of Alzheimer’s disease
title_full A longitudinal assessment of retinal function and structure in the APP/PS1 transgenic mouse model of Alzheimer’s disease
title_fullStr A longitudinal assessment of retinal function and structure in the APP/PS1 transgenic mouse model of Alzheimer’s disease
title_full_unstemmed A longitudinal assessment of retinal function and structure in the APP/PS1 transgenic mouse model of Alzheimer’s disease
title_short A longitudinal assessment of retinal function and structure in the APP/PS1 transgenic mouse model of Alzheimer’s disease
title_sort longitudinal assessment of retinal function and structure in the app/ps1 transgenic mouse model of alzheimer’s disease
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6774218/
https://www.ncbi.nlm.nih.gov/pubmed/31592131
http://dx.doi.org/10.1186/s40035-019-0170-z
work_keys_str_mv AT georgevskydana alongitudinalassessmentofretinalfunctionandstructureintheappps1transgenicmousemodelofalzheimersdisease
AT retsasstephanie alongitudinalassessmentofretinalfunctionandstructureintheappps1transgenicmousemodelofalzheimersdisease
AT raoufinewsha alongitudinalassessmentofretinalfunctionandstructureintheappps1transgenicmousemodelofalzheimersdisease
AT shimoniolga alongitudinalassessmentofretinalfunctionandstructureintheappps1transgenicmousemodelofalzheimersdisease
AT golzansmojtaba alongitudinalassessmentofretinalfunctionandstructureintheappps1transgenicmousemodelofalzheimersdisease
AT georgevskydana longitudinalassessmentofretinalfunctionandstructureintheappps1transgenicmousemodelofalzheimersdisease
AT retsasstephanie longitudinalassessmentofretinalfunctionandstructureintheappps1transgenicmousemodelofalzheimersdisease
AT raoufinewsha longitudinalassessmentofretinalfunctionandstructureintheappps1transgenicmousemodelofalzheimersdisease
AT shimoniolga longitudinalassessmentofretinalfunctionandstructureintheappps1transgenicmousemodelofalzheimersdisease
AT golzansmojtaba longitudinalassessmentofretinalfunctionandstructureintheappps1transgenicmousemodelofalzheimersdisease